They Are People First, Then Patients

Sponsored by Libo Pharma (Asia, Oceania)

LIB-101
開放性、單一組別試驗，評估倂用LIB-101在接受救援性化學治療的復發性/難治型瀰漫性大B細胞淋巴瘤(DLBCL)患者中之安全性、耐受性和初步療效